N-(2-(tert-butylamino)-1-(4-chlorophenyl)-2-oxoethyl)-7-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)-N-ethylhept-6-ynamide

ID: ALA4859643

PubChem CID: 164614255

Max Phase: Preclinical

Molecular Formula: C34H39ClN4O5

Molecular Weight: 619.16

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN(C(=O)CCCCC#Cc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O)C(C(=O)NC(C)(C)C)c1ccc(Cl)cc1

Standard InChI:  InChI=1S/C34H39ClN4O5/c1-5-38(30(32(43)37-34(2,3)4)23-15-17-24(35)18-16-23)29(41)14-9-7-6-8-11-22-12-10-13-25-26(22)21-39(33(25)44)27-19-20-28(40)36-31(27)42/h10,12-13,15-18,27,30H,5-7,9,14,19-21H2,1-4H3,(H,37,43)(H,36,40,42)

Standard InChI Key:  ICNQJWBMKKSVTJ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 44 47  0  0  0  0  0  0  0  0999 V2000
   20.6312  -25.4192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3195  -24.9721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0114  -24.5228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7440  -24.9000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4355  -24.4513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3926  -23.6265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9641  -23.7033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6493  -23.2533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4332  -22.4625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6142  -22.4238    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.3245  -23.1906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9491  -21.8187    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.1614  -21.7342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5369  -20.9956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0876  -20.3080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2634  -20.3511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8904  -21.0881    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.3416  -21.7819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8122  -19.6590    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.9695  -22.5183    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.6635  -26.0974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7092  -26.9212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4428  -27.2895    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.1311  -26.8423    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.0854  -26.0185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3514  -25.6419    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0193  -27.3737    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.4885  -28.1132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7979  -28.5647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2246  -28.4855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5264  -28.9374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3057  -24.8182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9961  -24.3668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7772  -25.5691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9262  -25.7273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5124  -25.9436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2042  -25.4942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9393  -25.8686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8819  -24.9045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1454  -24.5344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4552  -24.9880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5062  -25.8157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2430  -26.1820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7174  -24.6188    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  3  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  8  1  0
  7  3  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  7  1  0
  9 12  2  0
 10 13  1  0
 13 14  1  0
 13 18  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 16 19  2  0
 18 20  2  0
 21 22  1  0
 21 26  1  0
 22 23  1  0
 24 25  2  0
 25 26  1  0
 22 27  2  0
 23 28  1  0
 28 29  1  0
 28 30  1  0
 28 31  1  0
 26 32  1  0
 32 33  1  0
 25 34  1  0
 21 35  1  0
 34 36  1  0
 36 37  1  0
 37 38  1  0
 38  1  1  0
 35 39  2  0
 39 40  1  0
 40 41  2  0
 41 42  1  0
 42 43  2  0
 43 35  1  0
 41 44  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4859643

    ---

Associated Targets(Human)

RS4-11 (1012 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDM2 Tchem Protein cereblon/E3 ubiquitin-protein ligase Mdm2 (233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TP53 Tchem Cereblon/Tumour suppressor p53/oncoprotein Mdm2 (52 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CRBN Tclin Cereblon/GSPT1 (159 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 619.16Molecular Weight (Monoisotopic): 618.2609AlogP: 4.52#Rotatable Bonds: 9
Polar Surface Area: 115.89Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.61CX Basic pKa: CX LogP: 4.05CX LogD: 4.05
Aromatic Rings: 2Heavy Atoms: 44QED Weighted: 0.24Np Likeness Score: -0.71

References

1. Wang B, Liu J, Tandon I, Wu S, Teng P, Liao J, Tang W..  (2021)  Development of MDM2 degraders based on ligands derived from Ugi reactions: Lessons and discoveries.,  219  [PMID:33862513] [10.1016/j.ejmech.2021.113425]

Source